MBX Biosciences, Inc. MBX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $45.21M— | $75.29M— | $223.13M— | $39.78M— | —— | ||
| $394.76M— | $298.42M— | $168.55M— | $185.13M— | —— | ||
| $448.54M— | $381.54M— | $397.5M— | $229.19M— | —— | ||
| $3.13M— | $2.74M— | $2M— | $1.73M— | —— | ||
| $452.7M— | $385.14M— | $400.08M— | $231.52M— | —— | ||
| $19.48M+28.5% | $16.75M+47.1% | $19.11M+157% | $20.35M+699% | $15.16M+632% | ||
| $14.57M— | $15.5M— | $12.06M— | $11.76M— | —— | ||
| $14.95M— | $15.92M— | $12.54M— | $12.28M— | —— | ||
| $6K— | $6K— | $6K— | $5K— | —— | ||
| -$247.99M— | -$224.48M— | -$202.41M— | -$180.8M— | —— | ||
| $437.76M+85.9% | $369.22M+43.4% | $387.54M+42.8% | $219.24M+324% | $235.42M+383% | ||
| $452.7M— | $385.14M— | $400.08M— | $231.52M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are MBX Biosciences, Inc.'s total assets?
- MBX Biosciences, Inc. (MBX) holds $452.7M in total assets, up 84.1% year over year.
- How much debt does MBX Biosciences, Inc. have?
- MBX Biosciences, Inc. carries $555.0K in total debt against $437.8M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does MBX Biosciences, Inc. have?
- MBX Biosciences, Inc. holds $45.2M in cash and equivalents.
- Can MBX Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 30.79 — current assets exceed current liabilities.
- Where does MBX Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from MBX Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.